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ABSTRACT 
 
Hepatocellular carcinoma (HCC) is one of the most common malignancies in Asia. HCC expresses mRNA of melanoma 
antigen-1 (MAGE-1) and not expressed in non-tumor hepatic cells. This expression has been taking place at the early 
malignant transformation and continuously undergoing its progression. MAGE-1 is the important marker for diagnose 
HCC. MAGE-1 protein could be detected with antibody to MAGE-1 protein which could be obtained by doing clone of 
MAGE-1. However, the recombinant plasmid of MAGE-1 clone for developing of the diagnosis of HCC hasn’t been 
obtained. The objective was to clone of coding sequence (CDS) of MAGE-1 from fine needle aspiration biopsy (FNAB) 
of HCC into vector and to obtain MAGE-1 recombinant plasmid. cDNA of MAGE-1 were extracted then continued by 
RT PCR and nested PCR. The PCR product was cloned to pET101/D-TOPO and transformed to E. coli Top10. Analyze 
of recombinant plasmid was undertaken by sequencing and restriction test. The result revealed that CDS of MAGE-1 
were isolated and obtained band +1105 bp at first round and +931 bp at second round. The recombinant plasmid 
pETGM/MAGE1-HCC contained 927 nucleotides that encoded 309 amino acids. Partial sequence of MAGE-1 can be 
accessed in GeneBank EU161102 and ABW06861. Analyze of CDS MAGE-1 from HCC and GeneBank had 100% 
homology with  M77481 and NM_004988 (both from skin melanoma tissue) and 99% with BC017555 (from skin 
melanoma tissue) and AY148486 (from HCC). This study obtains recombinant plasmid pETGM/MAGE1-HCC from the 
FNAB of HCC. It reveals that MAGE-1 recombinant plasmid that can be used for developing the diagnosis of HCC 
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INTRODUCTION 
 
Hepatocellular carcinoma (HCC) is one of the most 
common malignancies in Asia and it is generally 
diagnosed at advanced stage, during which the 
prognosis of the patients has been poor and their 
capability to survive has also been low (Chen H, et al 
2000, Liu BB et al 1999). A number of studies have 
found that hepatic tissue of hepatocellular carcinoma 
patients expresses the melanoma antigen-1 (MAGE-1) 
gene in the form of mRNA between 60-80% (Peng et al 
2002, Mou et al 2002, Miyamoto et al 2000, Kariyama 
et al 1999, Chen et al 2000, Liu et al 1999, Zhao et al 
2004). MAGE-1 expressed in tumor with a size of less 
than 2 cm, normal or abnormal Alfhafeto protein (AFP) 
level, not expressed in non-tumor hepatic cells, not 
expressed in infectious of liver cells (Kobayashi et al 
2000). The expression of MAGE-1 mRNA in 
hepatocellular carcinoma is related with the deviation of 
genome hypomethylation and MAGE-1 promoter 
domain at element promoter B’ and B upstream -63 
until -46 (De Smet et al 1996, 1999, 2004, Xiao et al 
2005, Zhang et al 2004), This expression has been 
taking place at the early malignant transformation and 
continuously undergoing during its progression from 
hepatocelluler carcinoma. 
 
The melanoma antigen-1 (MAGE-1) gene, belongs to 
cancer tetis (CT) gene. The gene was firstly isolated 
from melanoma, and recognized as melanoma antigen 
(MAGE) gene (Kumar et al 2005, van Baren et al 1999). 
CT antigen has several particularities, i.e., 1) it is 
particularly expressed by tumor tissue and not in normal 
tissue, 2) CT antigen coding gene is located in 
chromosome X (Zhao et al 2004). MAGE-1 belongs to 
the antigens coded by MAGE gene family. This gene 
expressed by cancer cells, while it is not expressed in 
normal tissue except in the testis (Van Baren et al 1999, 
Luo et al 2002), so that this gene is specific for cancer. 
Such specificity can lead to a conclusion that each 
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MAGE-1 expression indicates the presence of cancer 
cells. MAGE-1 expression can be used as a prediction 
of hepatocellular carcinoma so that MAGE-1 is the 
important marker for diagnoses hepatocelluler 
carcinoma. MAGE-1 protein could be detected with 
antibody to MAGE-1 protein which could be obtained 
by doing clone of MAGE-1. However, the clone of 
coding sequence of MAGE-1 from the result of FNAB 
of hepatic tissue of hepatocellular carcinoma patients 
and recombinant plasmid of MAGE-1 for developing of 
the diagnosis of hepatocelluler carcinoma has not been 
obtained. 
 
mRNA of MAGE-1 can be carried out by using samples 
from hepatic tissue of patients with hepatocellular 
carcinoma. However, one of the obstacles found in 
carrying out MAGE-1 examination from hepatic biopsy 
tissue is the risk of uncontrolled bleeding. Another 
alternative is the use of samples from fine needle biopsy 
(FNAB). Unfortunately, due to limited cell counts 
aspirable with FNAB, the examination has to be 
conducted as effective as possible. To overcome these 
obstacles, examination should be undertaken in specific 
condition.  
 
This study was a laboratory explorative study intended 
to clone of coding sequence of MAGE-1 from the result 
of FNAB of hepatic tissue of hepatocellular carcinoma 
patients into vector and to obtain MAGE-1 recombinant 
plasmid. Isolated of coding sequence was conducted by 
nested PCR. The first round was covering exon 1, exon 
2, and exon 3 with total product 1105bp. This area is a 
conserved area for MAGE-1 (Chen et al 2000). The 
second round was covering in coding sequnce of 
MAGE-1 into exon 3 with total product 931bp.  
 
 
MATERIALS AND METHOD 
 
Samples were obtained from hepatocellular carcinoma 
by with fine needle aspiration biopsy (FNAB). 
Extraction of mRNA was referred to Takano T, et al 
(1999) and Giardia E, et al (2002) by lysis into needle. 
The result of FNAB taken by 22 or 24G needle with CT 
Scan as direction and directly put into tube containing 
lysis buffer, then pipetting and aspirate for 5 times for 
lysis into needle. Total RNA extraction was undertaken 
using RNeasy Protect Mini Kit (Qiagen) as protocol. 
cDNA synthesis was undertaken using First strand 
cDNA Syntesis kit for RT PCR (AMV) (Roche) which 
total RNA was subsequently altered into cDNA by 
means of oligo(T) primer. 
 
Formed cDNA was amplified with nested polymerase 
chain reaction (PCR) and done using 2X PCR master 
Mix (Fermentas).The first round of PCR was done with 
GMF421 primer was 5’-CGGCCGAAGGAACCT 
GACCCAG-3’ and GMTOPOR 5’-GCTTTGAGA 
GAGGAGGAAGAGGGAGTC-3’, producing 1105bp. 
The second round was done with GM TOPO F 
CACCATGTCTCTTGAGCAGAGGAGTC and 
GMTOPOR 5’-GCTTTGAGAGAGGAGGAAGA 
GGGAGTC-3’, producing 931bp. Primer concentration 
used for PCR was 50pmol/ml. Protocol was done 
according to sheat product data. The condition of PCR 
was the predenaturation was at 95oC for 5 minutes, 
denaturation at 95oC for 1 minute, annealing was 58oC 
1 minute, and extension at 72oC 1 minute, 31 cycles. 
The cycle was prolonged at 72oC for 10 minutes. The 
PCR product was electrophoresized with 2% 
electrophoresis gel and visualized with UV 
transluminator. PCR product was sequenced with 
GeneticSequenzer (ABI Prism 310). The product of 
second round nested PCR was cloned to the vector 
pET101/D-TOPO and transformed to E. coli Top10 to 
confirm the accomplishment of insertion. Analyze of 
recombinant plasmid was undertaken by sequencing to 
find the nucleotide sequence of target DNA and by 
restriction test to find cloning accomplishment.  
 
 
RESULTS 
 
The isolation of MAGE-1 gene mRNA was undertaken 
by extracting samles to obtain total RNA which was 
subsequently altered to become cDNA by using 
oligo(T) primer. Poly A presents at the 3' end of mRNA, 
so that oligo(T) would pair with the poly A. 
Subsequently, cDNA synthesis was undergone by 
reverse transcriptase enzyme. Formed cDNA was 
amplified with nested PCR. The first round of PCR was 
done with GMF421 primer was 5’-
CGGCCGAAGGAACCTGACCCAG-3’ and 
GMTOPOR 5’-GCTTTGAGAGAGGAGGAAGA 
GGGAGTC-3’. The second round was done with GM 
TOPOF CACCATGTCTCTTGAGCAGAGGAGTC 
and GMTOPOR 5’-GCTTTGAGAGAGGAG 
GAAGAGGGAGTC-3’. The condition of PCR was the 
pre denaturation was at 95oC for 5 minutes, 
denaturation at 95oC for 1 minute, annealing was 58oC 
1 minute, and extension at 72oC 1 minute, 31 cycles. 
The cycle was prolonged at 72oC for 10 minutes. The 
results of nested PCR was visualized by runing the 2% 
electrophoresis gel and documented. The result of this 
study obtained band + 1105bp at first round and + 
931bp at second round, as seen in Figure 1.  
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Figure 1. The electroforesis of nested PCR of the coding 
sequences of MAGE-1 gene from FNAB of 
hepatic tissue of carcinoma hepatocelluler 
patients. 1= the first round of PCR product (+ 
110¬5 bp), 2= the second round of PCR 
product (+ 931bp), M= Marker F x 174 RF 
DNA /Hae III fragments  
 
The product of second round nested PCR was cloned to 
the vector pET101/D-TOPO and transformed to E. coli 
Top10 to confirm the accomplishment of insertion. The 
result of transformation into E. coli Top 10 is shown at 
Figure 2. E. coli Top 10 growth on the Luria Bertani 
agar plate medium containing ampicillin for selection. 
E. coli Top 10 sensitive to ampicilin and pET101/D-
TOPO was designed with resistance gene for ampicilin 
so that only coloni which contain recombinant plasmid 
can grow on the medium.  
 
 
 
Figure 2.  The plasmid recombinant of pETGM/ 
MAGE1-HCC in transform cell E. coli 
Top10  
 
Analyze of recombinant plasmid was undertaken by 
restriction analyzing to find cloning accomplishment 
and sequencing to find the nucleotide sequence of target 
DNA. Restriction analyzed was performed using the 
EcoRV that cut the plasmid at the 545 and 4775 
nucleotides. The result of EcoRV restriction had band 
4230 and 2340 (1471 + 978). The coding sequence of 
MAGE-1 gene inserted in the number of 302 
nucleotides of pET101/D-TOPO. The full sequence of 
recombinant plasmid pETGM/MAGE1-HCC had 
6680pb (pET101/D-TOPO = 5753 and the coding 
sequence of mAGE-1= 927; 5773+927=6680). The 
result is shown at Figure 3.  
 
 
 
Figure 3. The EcoRV restriction analyze of pETGM/ 
MAGE1-HCC in transforms cell E. coli 
Top10. M= Marker DNA l cut with HindIII 
and EcoRI; 1= recombinant plasmid 
pETGM/MAGE1-HCC and 2= recombinant 
plasmid pETGM /MAGE1-HCC cut with 
EcoRV. 
 
Sequencing of the recombinant plasmid 
pETGM/MAGE1-HCC was performed using Genetic 
Sequenzer (ABI Prism 310). The sequence is shown at 
Figure 4. Partial sequence of MAGE-1 gene coding area 
can be accessed in GeneBank with accession number 
EU161102 for nucleotide and ABW06861 for protein. 
The coding sequence of MAGE-1 gene in the 
recombinant plasmid pETGM/MAGE1-HCC contained 
927 nucleotides that encoded 309 amino acids. The map 
of recombinant plasmid pETGM/MAGE1-HCC is 
shown at Figure 5. 
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Figure 4. Sequence of the full length of coding sequence 
of MAGE-1 gene from FNAB of hepatic tissue 
of carcinoma hepatocelluler patients.  
 
 
 
 
Figure 5. The map of recombinant plasmid 
pETGM/MAGE1-HCC from the FNAB 
of the hepatic tissue of carcinoma 
hepatocelluler patients contained 927 
nucleotides that encoded 309 amino acids.  
 
 
 
DISCUSSION 
 
This was a laboratory explorative study generally aimed 
to clone of coding sequence of MAGE-1 from the result 
of FNAB of hepatic tissue of hepatocellular carcinoma 
patients into vector and to obtain MAGE-1 recombinant 
plasmid. The benefit for scientific development of this 
study was to provide information on sequence of coding 
sequence of MAGE-from the result of FNAB of hepatic 
tissue of hepatocellular carcinoma patients. Practical 
benefit from this study was to obtain recombinant 
plasmid pETGM/MAGE1-HCC. The result can be used 
as a basis for further study on the exploration of 
MAGE-1 gene expression for developing of the 
diagnosis tools of hepatocelluler carcinoma.  
 
mRNAn isolation in this study used RNesay protect 
mini kit (Qiagen). Extraction protocol was carried out 
according to the kit employed in this study. The 
principle is that the mRNA was removed from cells by 
tissue lysis, chemically by mixing guanidium 
isotiocynate and betha mercaptoethanol, contained in 
buffer lysis, and enzymatically by using proteolytic 
enzyme, the proteinase K. Ethanol, which was added to 
prepare RNA binding condition with silica membrane 
on the column. Total RNA was bound to the column, 
while contaminants were washed efficiently. Finally, 
total RNA obtained was dissolved with RNase free 
water. Resulted RNA concentration using silica 
membrane column was 100 ug RNA. Total RNA could 
be kept at -30oC until the usage or could be directly 
used for cDNA synthesis (Qiagen 2001). 
 
Extraction from the FNAB result was done directly into 
needle by aspirating the lysis buffer and cell from 
FNAB solution for minimal 5 times. Lysis buffer 
contains guanidium isotiocynate and betha 
mercaptoethanol that potent chaotopic agent for lysis 
cells. Then it continued with enzymatic lysis using 
proteinase K. The result of extracton is total RNA that 
ready for reverse to be cDNA by Reverse trancriptase 
enzyme.  
 
cDNA was synthesized from total RNA with RT PCR 
(Reverse Trancriptase- Polymerase Chain Reaction). RT 
PCR is a method designed to amplify cDNA copy from 
RNA. Primers used for hybridizatoin was RT PCR are 
1) Gene Specific Primer (GSP), used for primer 
antisense (oligonucleotide antisense) from the sequence 
needed. Maximum result can be obtained if the primer 
antisense used for amplification in the PCR is located 
far upstream from the oligonucleotide used for cDNA 
synthesis. 2) Oligo(T) (dT), which binds endogeneous 
poly(A) tail that presents at 3' mRNA. This primer can 
be used as universal primer for synthesizing cDNA.      
3) Random hexanucleotide, which can be used to 
synthesize cDNA from long mRNA template. The 
primer can attach to all mRNA randomly, so that it can 
be used as template for cDNA synthesis in all mRNA 
(Sambrook & Russell 2001). Primer used for RT PCR in 
this study was oligo(T) as it could obtain total RNA that 
could be employed as a PCR template for all genes. The 
result of RT PCR is ready for amplified by nested PCR.  
 
Formed cDNA was amplified with nested PCR. The 
first round of PCR was done with GMF421 primer was 
5’-CGGCCGAAGGAACCTGACCCAG-3’ and 
GMTOPOR 5’-GCTTTGAGAGAGGAGGAA 
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GAGGGAGTC-3’. The second round was done with 
GMTOPOF CACCATGTCTCTTGAGCAGAG 
GAGTC and GMTOPOR 5’-GCTTTGAGAGA 
GGAGGAAGAGGGAGTC-3’. This second round 
primer was designed specific for purpose of cloning into 
pET101/D-TOPO. The result of this study obtained 
band + 1105bp at first round and + 931bp at second 
round.  
 
The primer GMTOPOF is forward direction and 
GMTOPOR is for reverse direction. The forward primer 
was added CACC sequenceat 5’ for direction into clone 
to pET101/D_TOPO and added ATG for start codon to 
synthesis protein. The reverse primer was missed stop 
codon because it uses the vector stop codon. Stop codon 
of vector was sited down stream of the insert site before 
histidine taq. The vector was already including the 6x 
histidine taq for make easy to purify the recombinant 
protein. The PCR product was purified then inserted 
into vector, pET101/D-TOPO and transformed into E. 
coli Top 10 for to confirm the accomplishment of 
insertion. E. coli Top 10 grow on the Luria Bertani agar 
plate medium containing ampicillin for selection. E. coli 
Top 10 sensitive to ampicilin can’t growt at medium 
containg ampicilin. and pET101/D-TOPO was designed 
with resistance gene for ampicilin so that only coloni 
which contain recombinant plasmid can grow on the 
medium.  
 
Analyze of recombinant plasmid was undertaken by 
restriction analyzing to find cloning accomplishment 
and sequencing to find the nucleotide sequence of target 
DNA. EcoRV cut pETGM/MAGE1-HCC at the 545 and 
4775 nucleotides. The result of EcoRV restriction had 
band 4230 and 2340 (1471 + 978). The coding sequence 
of MAGE-1 gene inserted in the number of 302 
nucleotides of pET101/D-TOPO. The full sequence of 
recombinant plasmid pETGM/MAGE1-HCC had 
6680pb (pET101/D-TOPO = 5753 and the coding 
sequence of mAGE-1= 927; 5773+927=6680). 
 
Sequencing of the recombinant plasmid 
pETGM/MAGE1-HCC was performed using Genetic 
Sequenzer (ABI Prism 310). The sequence is shown at 
Figure 4. Partial sequence of MAGE-1 gene coding area 
can be accessed in GeneBank with accession number 
EU161102 for nucleotide and ABW06861 for protein. 
The coding sequence of MAGE-1 gene in the 
recombinant plasmid pETGM/MAGE1-HCC contained 
927 nucleotides that encoded 309 amino acids. The map 
of recombinant plasmid pETGM/MAGE1-HCC is 
shown at Figure 5. 
 
MAGE-1 gene contents 3 exons, and 2 introns. The 
coding sequence of MAGE-1 sited at exon 3, at 188-
1117 nucleotide. mRNA MAGE-1 content 1722 
nucleotides, coding sequence at nucleotides 188-1117 
(927bp nucleotide include start codon without stop 
codon). This vector pET101/D-TOPO is 5753bp and 
linier so that it can use as direct cloning from PCR 
product without restriction before used. The coding 
sequence of MAGE-1 is 927bp so that the total long of 
recombinant plasmid pETGM/MAGE1-HCC is 6680bp. 
The sequence of MAGE-1 gene coding area can be 
accessed in GeneBank with accession number 
EU161102 for nucleotide and ABW06861 for protein. 
Analyze of the coding sequence of MAGE-1 gene from 
hepatic tissue of hepatocellular carcinoma patient and 
GeneBank had 100% homology with sequence 
accession number M77481 (sequence from skin 
melanoma tissue), NM_004988 (sequence from skin 
melanoma tissue) and 99% with sequence accession 
number BC017555 (sequence from skin melanoma 
tissue) and AY148486 (from hepatocellular carcinoma 
patient's hepatic tissue).  
 
 
CONCLUSION 
 
This study obtains recombinant plasmid 
pETGM/MAGE1-HCC from the FNAB of hepatic 
tissue of hepatocellular carcinoma. It reveals that 
MAGE-1 recombinant plasmid that can be used for 
developing the diagnosis of hepatocellular carcinoma. 
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